Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Critical Illness

3,4-dihydroxyphenylacetic acid has been researched along with Critical Illness in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Critical Illness: A disease or state in which death is possible or imminent.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moussouttas, M1
Lai, EW1
Khoury, J1
Huynh, TT1
Dombrowski, K1
Pacak, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Myocardial Dysfunction at Early Phase of Traumatic Brain Injury : Evaluation by Two Dimensional and Speckle Tracking Transthoracic Echocardiography[NCT02380482]40 participants (Actual)Interventional2014-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Critical Illness

ArticleYear
Determinants of central sympathetic activation in spontaneous primary subarachnoid hemorrhage.
    Neurocritical care, 2012, Volume: 16, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Critical Illness; Dihydroxyphenylala

2012